The Nordic-HILUS Trial: Ultracentral Lung Stereotactic Ablative Radiotherapy and a Narrow Therapeutic Window

Stephen A Rosenberg¹, Raymond Mak², Rupesh Kotecha³, Bill W Loo Jr⁴, Suresh Senan⁵

Affiliations

¹ Department of Radiation Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida. Electronic address: stephen.rosenberg@moffitt.org.
² Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
³ Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, Florida.
⁴ Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California.
⁵ Department of Radiation Oncology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.

PMID: 34561039
DOI: 10.1016/j.jtho.2021.06.030

Free article

Comment

The Nordic-HILUS Trial: Ultracentral Lung Stereotactic Ablative Radiotherapy and a Narrow Therapeutic Window

Stephen A Rosenberg et al. J Thorac Oncol. 2021 Oct.

Free article

. 2021 Oct;16(10):e79-e80.

doi: 10.1016/j.jtho.2021.06.030.

Authors

Stephen A Rosenberg¹, Raymond Mak², Rupesh Kotecha³, Bill W Loo Jr⁴, Suresh Senan⁵

Affiliations

¹ Department of Radiation Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida. Electronic address: stephen.rosenberg@moffitt.org.
² Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
³ Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, Florida.
⁴ Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California.
⁵ Department of Radiation Oncology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.

PMID: 34561039
DOI: 10.1016/j.jtho.2021.06.030

No abstract available

PubMed Disclaimer

Comment in

In Response to Rosenberg et al. "The Nordic-HILUS Trial: Ultracentral Lung SABR and a Narrow Therapeutic Window".
Lindberg K, Lax I, Karlsson K, Lewensohn R. Lindberg K, et al. J Thorac Oncol. 2021 Oct;16(10):e81-e82. doi: 10.1016/j.jtho.2021.08.005. J Thorac Oncol. 2021. PMID: 34561040 No abstract available.

Comment on

The HILUS-Trial-a Prospective Nordic Multicenter Phase 2 Study of Ultracentral Lung Tumors Treated With Stereotactic Body Radiotherapy.
Lindberg K, Grozman V, Karlsson K, Lindberg S, Lax I, Wersäll P, Persson GF, Josipovic M, Khalil AA, Moeller DS, Nyman J, Drugge N, Bergström P, Olofsson J, Rogg LV, Ramberg C, Kristiansen C, Jeppesen SS, Nielsen TB, Lödén B, Rosenbrand HO, Engelholm S, Haraldsson A, Billiet C, Lewensohn R. Lindberg K, et al. J Thorac Oncol. 2021 Jul;16(7):1200-1210. doi: 10.1016/j.jtho.2021.03.019. Epub 2021 Apr 3. J Thorac Oncol. 2021. PMID: 33823286 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Associated data

Actions
- Search in PubMed
- Search in ClinicalTrials.gov
Actions
- Search in PubMed
- Search in ClinicalTrials.gov
Actions
- Search in PubMed
- Search in ClinicalTrials.gov

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Medical
- ClinicalTrials.gov
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

The Nordic-HILUS Trial: Ultracentral Lung Stereotactic Ablative Radiotherapy and a Narrow Therapeutic Window

Affiliations

The Nordic-HILUS Trial: Ultracentral Lung Stereotactic Ablative Radiotherapy and a Narrow Therapeutic Window

Authors

Affiliations

Comment in

Comment on

Publication types

MeSH terms

Associated data

LinkOut - more resources

Full Text Sources

Medical